The Latest Breaking News from AngioDynamics Inc

3 Growth Stocks Under $10 That Analysts Predict Will Skyrocket

Gradually lowering inflation and reducing borrowing rates have opened new and exciting doors for growth stocks. With a positive economic outlook, investors could keep a watchful eye on Esperion Therapeutics (ESPR), AngioDynamics (ANGO), and Fathom Holdings (FTHM) to capitalize on the growing economy. Continue Reading….

StockNews.com · Nov 14, 2024

AngioDynamics Posts Wider Q3 Loss On Higher Costs, Reaffirms FY22 Outlook

AngioDynamics Inc (NASDAQ:ANGO) has reported a Q3 FY22 adjusted EPS of $0.03, ahead of the consensus of $(0.01), and better than the consensus of $0.02 reported a year ago. Q3 sales increased 3.9% Y/Y to $73.97 million, missing the analyst consensus of $76.32 million. Endovascular Therapies net sales increased 14.5% to $38.1…

Benzinga · Apr 7, 2022